chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chest discomfort, Chills, Dizziness, Fatigue
Clinical narrative: hot flashes; dizziness; feels pressure on chest when she lays down at night; tiredness; chills (on & off throughout the day); achy bones; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (achy bones), HOT FLUSH (hot flashes), DIZZINESS (dizziness), CHEST DISCOMFORT (feels pressure on chest when she lays down at night) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. MoD011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sinus pain. Concurrent medical conditions included Allergy.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced BONE PAIN (achy bones) and HEADACHE (Headache). On an unknown date, the patient experienced HOT FLUSH (hot flashes), DIZZINESS (dizziness), CHEST DISCOMFORT (feels pressure on chest when she lays down at night), FATIGUE (tiredness) and CHILLS (chills (on & off throughout the day)). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, BONE PAIN (achy bones), HOT FLUSH (hot flashes), DIZZINESS (dizziness), CHEST DISCOMFORT (feels pressure on chest when she lays down at night), HEADACHE (Headache), FATIGUE (tiredness) and CHILLS (chills (on & off throughout the day)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush
Clinical narrative: hot flashes; dizziness; feels pressure on chest when she lays down at night; tiredness; chills (on & off throughout the day); achy bones; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (achy bones), HOT FLUSH (hot flashes), DIZZINESS (dizziness), CHEST DISCOMFORT (feels pressure on chest when she lays down at night) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. MoD011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sinus pain. Concurrent medical conditions included Allergy.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced BONE PAIN (achy bones) and HEADACHE (Headache). On an unknown date, the patient experienced HOT FLUSH (hot flashes), DIZZINESS (dizziness), CHEST DISCOMFORT (feels pressure on chest when she lays down at night), FATIGUE (tiredness) and CHILLS (chills (on & off throughout the day)). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, BONE PAIN (achy bones), HOT FLUSH (hot flashes), DIZZINESS (dizziness), CHEST DISCOMFORT (feels pressure on chest when she lays down at night), HEADACHE (Headache), FATIGUE (tiredness) and CHILLS (chills (on & off throughout the day)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: experienced sore right arm,; experienced sore right arm, and chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (experienced sore right arm,) and CHILLS (experienced sore right arm, and chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L220A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included HYDROCORTISONE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (experienced sore right arm,) and CHILLS (experienced sore right arm, and chills). The patient was treated with IBUPROFEN on 27-Jan-2021 at an unspecified dose and frequency. On 30-Jan-2021, PAIN IN EXTREMITY (experienced sore right arm,) and CHILLS (experienced sore right arm, and chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were hydrocortisone 5-10mg, Thyroid medication, and supplements for drug use for unknown indication.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Fatigue, Myalgia, Nausea
Clinical narrative: nausea; back pain; low energy; Fatigue; muscles pain; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), BACK PAIN (back pain), ASTHENIA (low energy), FATIGUE (Fatigue) and MYALGIA (muscles pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN and LISINOPRIL for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced NAUSEA (nausea), BACK PAIN (back pain), ASTHENIA (low energy), FATIGUE (Fatigue) and MYALGIA (muscles pain). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency. At the time of the report, NAUSEA (nausea), BACK PAIN (back pain), ASTHENIA (low energy), FATIGUE (Fatigue) and MYALGIA (muscles pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Light headiness; Later had a rash; Fatigue; Body ache; Chills; Nausea; Vomiting; Headache severe; Had temperature of 101.7; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), HEADACHE (Headache severe) and PYREXIA (Had temperature of 101.7). At the time of the report, DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), HEADACHE (Headache severe) and PYREXIA (Had temperature of 101.7) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.7 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: The email address was corrected on 14Jul2021.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Rash, Vomiting
Clinical narrative: Light headiness; Later had a rash; Fatigue; Body ache; Chills; Nausea; Vomiting; Headache severe; Had temperature of 101.7; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), HEADACHE (Headache severe) and PYREXIA (Had temperature of 101.7). At the time of the report, DIZZINESS (Light headiness), RASH (Later had a rash), FATIGUE (Fatigue), MYALGIA (Body ache), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), HEADACHE (Headache severe) and PYREXIA (Had temperature of 101.7) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.7 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: The email address was corrected on 14Jul2021.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Infection
Clinical narrative: infection NOS; This spontaneous case was reported by a consumer and describes the occurrence of INFECTION (infection NOS) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced INFECTION (infection NOS). At the time of the report, INFECTION (infection NOS) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site mass, Vaccination site rash, Vaccination site warmth
Clinical narrative: Injection site warm; Injection site Pink; Injection site raised; rash appeared around the injection site/rash is of the size of her palm (6x8 cm); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE DISCOLOURATION (Injection site Pink), VACCINATION SITE MASS (Injection site raised) and VACCINATION SITE RASH (rash appeared around the injection site/rash is of the size of her palm (6x8 cm)) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE DISCOLOURATION (Injection site Pink), VACCINATION SITE MASS (Injection site raised) and VACCINATION SITE RASH (rash appeared around the injection site/rash is of the size of her palm (6x8 cm)). The patient was treated with CORTISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE DISCOLOURATION (Injection site Pink), VACCINATION SITE MASS (Injection site raised) and VACCINATION SITE RASH (rash appeared around the injection site/rash is of the size of her palm (6x8 cm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included blood pressure pills.  Treatments also included cool compress.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness in the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in the arm of injection) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness in the arm of injection). At the time of the report, VACCINATION SITE PAIN (Soreness in the arm of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itching at her injection site; A 4cm circle of red rash at injection site; A 4cm circle of red rash at injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PRURITUS (Itching at her injection site), VACCINATION SITE RASH (A 4cm circle of red rash at injection site) and VACCINATION SITE ERYTHEMA (A 4cm circle of red rash at injection site) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Sleep disorder NOS.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at her injection site), VACCINATION SITE RASH (A 4cm circle of red rash at injection site) and VACCINATION SITE ERYTHEMA (A 4cm circle of red rash at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching at her injection site), VACCINATION SITE RASH (A 4cm circle of red rash at injection site) and VACCINATION SITE ERYTHEMA (A 4cm circle of red rash at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: Follow up received on 24 Apr 2021. No new information were reported.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Experienced pain on the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Experienced pain on the injection arm) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (Experienced pain on the injection arm). On 22-Jan-2021, VACCINATION SITE PAIN (Experienced pain on the injection arm) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient did not want to be contacted. He said his side effect got better. No concomitant medications were reported. No treatment information was reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: Patient did not want to be contacted.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Heart rate, Illness, Myalgia
Clinical narrative: I've been pretty sick since 9 o'clock last night; From head to toe, my body just hurts to no end; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I've been pretty sick since 9 o'clock last night) and MYALGIA (From head to toe, my body just hurts to no end) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ILLNESS (I've been pretty sick since 9 o'clock last night) and MYALGIA (From head to toe, my body just hurts to no end). At the time of the report, ILLNESS (I've been pretty sick since 9 o'clock last night) and MYALGIA (From head to toe, my body just hurts to no end) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Blood pressure measurement: 132/86 (High) 132/86  units not provided.. On 08-Feb-2021, Body temperature: 96.7 96.7 units not provided.. On 08-Feb-2021, Heart rate: 82 82  units not provided..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Pyrexia, Vomiting
Clinical narrative: very weak; Diarrhea and went to the bathroom for 6-7 time; vomiting and has vomited 6-7 times; chills; a fever of 100.3 deg F.; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (very weak), DIARRHOEA (Diarrhea and went to the bathroom for 6-7 time), VOMITING (vomiting and has vomited 6-7 times), CHILLS (chills) and PYREXIA (a fever of 100.3 deg F.) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ASTHENIA (very weak), DIARRHOEA (Diarrhea and went to the bathroom for 6-7 time), VOMITING (vomiting and has vomited 6-7 times), CHILLS (chills) and PYREXIA (a fever of 100.3 deg F.). The patient was treated with BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ASTHENIA (very weak), DIARRHOEA (Diarrhea and went to the bathroom for 6-7 time), VOMITING (vomiting and has vomited 6-7 times), CHILLS (chills) and PYREXIA (a fever of 100.3 deg F.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Pyrexia: 100.3 Farad (High) 100.3 deg F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported birth control medication.  Treatment included Gatorade and water.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Migraine
Clinical narrative: The headache has started off and on. It has gotten worse and felt like a migraine behind the left; fatigue; headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of MIGRAINE (The headache has started off and on. It has gotten worse and felt like a migraine behind the left), FATIGUE (fatigue) and HEADACHE (headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced MIGRAINE (The headache has started off and on. It has gotten worse and felt like a migraine behind the left), FATIGUE (fatigue) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MIGRAINE (The headache has started off and on. It has gotten worse and felt like a migraine behind the left), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  Treatment details included At 4:15AM, he took 2 Tylenol tablets that morning. On 07 Feb 2021, he took 2 Tylenol tablets at, 4PM and nothing today.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: significant lip swelling and facial swelling; significant lip swelling and facial swelling; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (significant lip swelling and facial swelling) and LIP SWELLING (significant lip swelling and facial swelling) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE and LOSARTAN for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced SWELLING FACE (significant lip swelling and facial swelling) and LIP SWELLING (significant lip swelling and facial swelling). On 06-Feb-2021, SWELLING FACE (significant lip swelling and facial swelling) and LIP SWELLING (significant lip swelling and facial swelling) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included IV steroids and IV fluids.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness, Electrocardiogram, Fatigue, Hypertension
Clinical narrative: pain in arm; body aches; started feeling so tired/  hard time staying up; blood pressure was high; lightheaded; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (pain in arm), MYALGIA (body aches), FATIGUE (started feeling so tired/  hard time staying up), HYPERTENSION (blood pressure was high) and DIZZINESS (lightheaded) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Hypercholesterolemia and Allergy to allopathic drugs (Drugs include NSAID's diltiazem and triamterene.). Concomitant products included LOSARTAN, METOPROLOL, PRAVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN) and COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), MYALGIA (body aches), FATIGUE (started feeling so tired/  hard time staying up), HYPERTENSION (blood pressure was high) and DIZZINESS (lightheaded). The patient was treated with DIAZEPAM (VALIUM) at an unspecified dose and frequency and ALPRAZOLAM (XANAX) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in arm), MYALGIA (body aches), FATIGUE (started feeling so tired/  hard time staying up), HYPERTENSION (blood pressure was high) and DIZZINESS (lightheaded) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Blood pressure measurement: 109/104 (High) At 8 P.M and 200/100 (Inconclusive) At midnight. On 01-Feb-2021, Electrocardiogram: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: pain in arm; body aches; started feeling so tired/  hard time staying up; blood pressure was high; lightheaded; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (pain in arm), MYALGIA (body aches), FATIGUE (started feeling so tired/  hard time staying up), HYPERTENSION (blood pressure was high) and DIZZINESS (lightheaded) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Hypercholesterolemia and Allergy to allopathic drugs (Drugs include NSAID's diltiazem and triamterene.). Concomitant products included LOSARTAN, METOPROLOL, PRAVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN) and COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), MYALGIA (body aches), FATIGUE (started feeling so tired/  hard time staying up), HYPERTENSION (blood pressure was high) and DIZZINESS (lightheaded). The patient was treated with DIAZEPAM (VALIUM) at an unspecified dose and frequency and ALPRAZOLAM (XANAX) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in arm), MYALGIA (body aches), FATIGUE (started feeling so tired/  hard time staying up), HYPERTENSION (blood pressure was high) and DIZZINESS (lightheaded) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Blood pressure measurement: 109/104 (High) At 8 P.M and 200/100 (Inconclusive) At midnight. On 01-Feb-2021, Electrocardiogram: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: Shortness of breath; Felt flu-like; Injection site pain; Headache; Muscle aches; Chills; Joint pain; Fever of 101 F; Fatigue; Swollen lymph nodes; This spontaneous case was reported by a nurse and describes the occurrence of DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Felt flu-like), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache) and MYALGIA (Muscle aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021 at 7:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Felt flu-like), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), MYALGIA (Muscle aches), CHILLS (Chills), ARTHRALGIA (Joint pain), PYREXIA (Fever of 101 F), FATIGUE (Fatigue) and LYMPHADENOPATHY (Swollen lymph nodes). In February 2021, DYSPNOEA (Shortness of breath) outcome was unknown, INFLUENZA LIKE ILLNESS (Felt flu-like), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), MYALGIA (Muscle aches), CHILLS (Chills) and LYMPHADENOPATHY (Swollen lymph nodes) had resolved. At the time of the report, ARTHRALGIA (Joint pain) and PYREXIA (Fever of 101 F) had resolved and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lymphadenopathy, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Shortness of breath; Felt flu-like; Injection site pain; Headache; Muscle aches; Chills; Joint pain; Fever of 101 F; Fatigue; Swollen lymph nodes; This spontaneous case was reported by a nurse and describes the occurrence of DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Felt flu-like), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache) and MYALGIA (Muscle aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021 at 7:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), INFLUENZA LIKE ILLNESS (Felt flu-like), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), MYALGIA (Muscle aches), CHILLS (Chills), ARTHRALGIA (Joint pain), PYREXIA (Fever of 101 F), FATIGUE (Fatigue) and LYMPHADENOPATHY (Swollen lymph nodes). In February 2021, DYSPNOEA (Shortness of breath) outcome was unknown, INFLUENZA LIKE ILLNESS (Felt flu-like), VACCINATION SITE PAIN (Injection site pain), HEADACHE (Headache), MYALGIA (Muscle aches), CHILLS (Chills) and LYMPHADENOPATHY (Swollen lymph nodes) had resolved. At the time of the report, ARTHRALGIA (Joint pain) and PYREXIA (Fever of 101 F) had resolved and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching all Over Body; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching all Over Body) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PRURITUS (Itching all Over Body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency; PREDNISONE at an unspecified dose and frequency and METHYLPREDNISOLONE (MEDROL DOSEPAK) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching all Over Body) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 14-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Tenderness
Clinical narrative: sore arm; little tenderness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and TENDERNESS (little tenderness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and TENDERNESS (little tenderness). At the time of the report, PAIN IN EXTREMITY (sore arm) and TENDERNESS (little tenderness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Pyrexia
Clinical narrative: Soreness in arm; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Soreness in arm), PYREXIA (Fever) and CHILLS (Chills) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced AXILLARY PAIN (Soreness in arm), PYREXIA (Fever) and CHILLS (Chills). On 07-Feb-2021, PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, AXILLARY PAIN (Soreness in arm) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: chills; severe severe headache, just pounding; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and HEADACHE (severe severe headache, just pounding) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced CHILLS (chills) and HEADACHE (severe severe headache, just pounding). At the time of the report, CHILLS (chills) and HEADACHE (severe severe headache, just pounding) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment medication was reported.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash in multiple locations; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (rash in multiple locations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH (rash in multiple locations). The patient was treated with PREDNISONE ongoing since an unknown date at a dose of 60 milligram; HYDROXYZINE HYDROCHLORIDE (HYDROXIZINE) ongoing since an unknown date at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RASH (rash in multiple locations) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment related information has been reported.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Vaccination site erythema, Vaccination site induration, Vaccination site mass, Vaccination site pruritus
Clinical narrative: he's experiencing side effects 8 days later; It was very bumpy; hardness at the injection site/ it felt hard to the touch; Itching at the injection site/ it was itchy; Redness at the injection site/m it was red; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (he's experiencing side effects 8 days later), VACCINATION SITE MASS (It was very bumpy), VACCINATION SITE INDURATION (hardness at the injection site/ it felt hard to the touch), VACCINATION SITE PRURITUS (Itching at the injection site/ it was itchy) and VACCINATION SITE ERYTHEMA (Redness at the injection site/m it was red) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 08-Feb-2021, the patient experienced ADVERSE DRUG REACTION (he's experiencing side effects 8 days later), VACCINATION SITE MASS (It was very bumpy), VACCINATION SITE INDURATION (hardness at the injection site/ it felt hard to the touch), VACCINATION SITE PRURITUS (Itching at the injection site/ it was itchy) and VACCINATION SITE ERYTHEMA (Redness at the injection site/m it was red).   At the time of the report, ADVERSE DRUG REACTION (he's experiencing side effects 8 days later), VACCINATION SITE MASS (It was very bumpy), VACCINATION SITE INDURATION (hardness at the injection site/ it felt hard to the touch), VACCINATION SITE PRURITUS (Itching at the injection site/ it was itchy) and VACCINATION SITE ERYTHEMA (Redness at the injection site/m it was red) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Arthralgia, Axillary pain, Gait disturbance, Haematoma
Clinical narrative: terribly sensitive leg; trouble walking; ankle was terribly painful; leg on injection side, especially ankle was terribly painful; severe hematoma/hematoma ran from her bicep to her hand; nearly turned back; very painful; severe reaction; barely could move her arm/barely stand to move; arm swelled; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATOMA (severe hematoma/hematoma ran from her bicep to her hand), ADVERSE DRUG REACTION (severe reaction), MOBILITY DECREASED (barely could move her arm/barely stand to move), PERIPHERAL SWELLING (arm swelled) and SKIN DISCOLOURATION (nearly turned back) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0152M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) and ACETYLSALICYLIC ACID (ASPRIN) for an unknown indication.  On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Feb-2021, the patient experienced ADVERSE DRUG REACTION (severe reaction), MOBILITY DECREASED (barely could move her arm/barely stand to move), PERIPHERAL SWELLING (arm swelled) and PAIN (very painful).   On 06-Feb-2021, the patient experienced HAEMATOMA (severe hematoma/hematoma ran from her bicep to her hand) and SKIN DISCOLOURATION (nearly turned back).   On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (terribly sensitive leg), GAIT DISTURBANCE (trouble walking), ARTHRALGIA (ankle was terribly painful) and AXILLARY PAIN (leg on injection side, especially ankle was terribly painful).   At the time of the report, HAEMATOMA (severe hematoma/hematoma ran from her bicep to her hand), ADVERSE DRUG REACTION (severe reaction), MOBILITY DECREASED (barely could move her arm/barely stand to move), PERIPHERAL SWELLING (arm swelled), SKIN DISCOLOURATION (nearly turned back), PAIN (very painful), PAIN IN EXTREMITY (terribly sensitive leg), GAIT DISTURBANCE (trouble walking), ARTHRALGIA (ankle was terribly painful) and AXILLARY PAIN (leg on injection side, especially ankle was terribly painful) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient's treatment plan included that at the ER patient's arm was wrapped with gauze and put her arm in a sling. Patient has been advised to apply pressure and limit movement.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain, Pain in extremity, Peripheral swelling, Skin discolouration
Clinical narrative: terribly sensitive leg; trouble walking; ankle was terribly painful; leg on injection side, especially ankle was terribly painful; severe hematoma/hematoma ran from her bicep to her hand; nearly turned back; very painful; severe reaction; barely could move her arm/barely stand to move; arm swelled; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATOMA (severe hematoma/hematoma ran from her bicep to her hand), ADVERSE DRUG REACTION (severe reaction), MOBILITY DECREASED (barely could move her arm/barely stand to move), PERIPHERAL SWELLING (arm swelled) and SKIN DISCOLOURATION (nearly turned back) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0152M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) and ACETYLSALICYLIC ACID (ASPRIN) for an unknown indication.  On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Feb-2021, the patient experienced ADVERSE DRUG REACTION (severe reaction), MOBILITY DECREASED (barely could move her arm/barely stand to move), PERIPHERAL SWELLING (arm swelled) and PAIN (very painful).   On 06-Feb-2021, the patient experienced HAEMATOMA (severe hematoma/hematoma ran from her bicep to her hand) and SKIN DISCOLOURATION (nearly turned back).   On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (terribly sensitive leg), GAIT DISTURBANCE (trouble walking), ARTHRALGIA (ankle was terribly painful) and AXILLARY PAIN (leg on injection side, especially ankle was terribly painful).   At the time of the report, HAEMATOMA (severe hematoma/hematoma ran from her bicep to her hand), ADVERSE DRUG REACTION (severe reaction), MOBILITY DECREASED (barely could move her arm/barely stand to move), PERIPHERAL SWELLING (arm swelled), SKIN DISCOLOURATION (nearly turned back), PAIN (very painful), PAIN IN EXTREMITY (terribly sensitive leg), GAIT DISTURBANCE (trouble walking), ARTHRALGIA (ankle was terribly painful) and AXILLARY PAIN (leg on injection side, especially ankle was terribly painful) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient's treatment plan included that at the ER patient's arm was wrapped with gauze and put her arm in a sling. Patient has been advised to apply pressure and limit movement.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Discomfort, Injection site movement impairment, Vaccination site pain, Vaccination site swelling
Clinical narrative: Discomfort was worse; injection site swelling; injection site pain; Her arm was painful; Limited range of Motion; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MOVEMENT IMPAIRMENT (Limited range of Motion), DISCOMFORT (Discomfort was worse), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site pain) and AXILLARY PAIN (Her arm was painful) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.  On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 03-Feb-2021, the patient experienced INJECTION SITE MOVEMENT IMPAIRMENT (Limited range of Motion), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site pain) and AXILLARY PAIN (Her arm was painful).   On 04-Feb-2021, the patient experienced DISCOMFORT (Discomfort was worse).   At the time of the report, INJECTION SITE MOVEMENT IMPAIRMENT (Limited range of Motion), DISCOMFORT (Discomfort was worse), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site pain) and AXILLARY PAIN (Her arm was painful) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.